Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
Butler
P C
PC
Larry Hillblom Islet Research Center at David Geffen School of Medicine, UCLA, Los Angeles, CA 90024-2852, USA. pbutler@mednet.ucla.edu
Matveyenko
A V
AV
Dry
S
S
Bhushan
A
A
Elashoff
R
R
D000818:Animals; D004195:Disease Models, Animal; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use*; D006801:Humans; D006965:Hyperplasia / Q000188:drug therapy; D046790:Pancreas, Exocrine / Q000187:drug effects*; D010183:Pancreatic Ducts / Q000187:drug effects / Q000473:pathology; D010195:Pancreatitis / Q000188:drug therapy*; D050500:Pancreatitis, Chronic / Q000188:drug therapy / Q000503:physiopathology; D051381:Rats; D014481:United States; D014486:United States Food and Drug Administration
D052216:Glucagon-Like Peptide 1